MedTrace Logo

Screening for Familial Gastric Cancer in First Degree Relatives

NCT01727908 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2019-09-16

No results posted yet for this study

Summary

The purpose of this study is to determine whether staining of the gastric mucosa increases the number of detected (pre)malignant foci of intestinal and diffuse type gastric cancer, in first degree relatives of individuals with familial gastric cancer.

Conditions

  • Malignant Neoplasm of Stomach
  • Carcinoma, Diffuse Type
  • Intestinal Type Adenocarcinoma of Stomach
  • Relative (Related Person)

Interventions

OTHER

Endoscopy with staining of the mucosa

Staining of the gastric mucosa with acetic acid and Indigocarmine

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Tanya M Bisseling, M.D.Ph.D. · Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre

  • Fokko M Nagengast, M.D.Ph.D. · Department of Gastroenterology and Hepatology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01727908 on ClinicalTrials.gov